A phase I, dose finding, pharmacokinetic, and safety study of continuous IV [intravenous] infusion of ECO-4601 [TLN 4601] in patients with advanced cancer including an extension portion to obtain safety data at the highest tolerable dose.

Trial Profile

A phase I, dose finding, pharmacokinetic, and safety study of continuous IV [intravenous] infusion of ECO-4601 [TLN 4601] in patients with advanced cancer including an extension portion to obtain safety data at the highest tolerable dose.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 13 Oct 2009

At a glance

  • Drugs Diazepinomicin (Primary)
  • Indications Breast cancer; Colorectal cancer; Lung cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Solid tumours
  • Focus Adverse reactions
  • Sponsors BELLUS Health
  • Most Recent Events

    • 10 Jul 2008 Status changed from in progress to completed, from clinicaltrials.gov record.
    • 22 Aug 2007 Status changed from recruiting to in progress.
    • 01 Jun 2007 Interim results have been reported
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top